Ubs Asset Management Americas Inc Moderna, Inc. Transaction History
Ubs Asset Management Americas Inc
- $446 Billion
- Q3 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,960,968 shares of MRNA stock, worth $48.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,960,968
Previous 3,023,227
35.14%
Holding current value
$48.6 Million
Previous $83.4 Million
39.27%
% of portfolio
0.01%
Previous 0.02%
Shares
24 transactions
Others Institutions Holding MRNA
# of Institutions
845Shares Held
257MCall Options Held
39.6MPut Options Held
43.1M-
Vanguard Group Inc Valley Forge, PA41.2MShares$1.02 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$633 Million0.07% of portfolio
-
Baillie Gifford & CO21.8MShares$541 Million0.44% of portfolio
-
State Street Corp Boston, MA17.1MShares$424 Million0.02% of portfolio
-
Morgan Stanley New York, NY9.96MShares$247 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $9.69B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...